title: T-cell prolymphocytic leukemia: survival improves with alemtuzemab, but stem cell transplant eligibility 'counts' even more.
authors: a Haematopathology Unit , Hospital Clinic of Barcelona , Spain and.
authors: Estella
authors: E
authors: Matutes
authors: b Department of Hematology , Hadassah University Hospital and Hebrew University Medical School , Jerusalem , Israel.
authors: Aaron
authors: A
authors: Polliack
mesh_terms: D006801:Humans; D015463:Leukemia, Prolymphocytic; D015461:Leukemia, Prolymphocytic, T-Cell; D015458:Leukemia, T-Cell; D033581:Stem Cell Transplantation